Folgen
Jan Oldenburg
Jan Oldenburg
University of Oslo, Onc Dept, Akershus University Hospital
Bestätigte E-Mail-Adresse bei medisin.uio.no
Titel
Zitiert von
Zitiert von
Jahr
Guidelines on testicular cancer: 2015 update
P Albers, W Albrecht, F Algaba, C Bokemeyer, G Cohn-Cedermark, ...
European urology 68 (6), 1054-1068, 2015
6952015
EAU guidelines on testicular cancer: 2011 update
P Albers, W Albrecht, F Algaba, C Bokemeyer, G Cohn-Cedermark, ...
European urology 60 (2), 304-319, 2011
4632011
Testicular cancer survivorship: research strategies and recommendations
LB Travis, C Beard, JM Allan, AA Dahl, DR Feldman, J Oldenburg, ...
Journal of the national cancer institute 102 (15), 1114-1130, 2010
3242010
Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J Oldenburg, SD Fosså, J Nuver, A Heidenreich, HJ Schmoll, ...
Annals of Oncology 24, vi125-vi132, 2013
3202013
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ...
Annals of oncology 24 (4), 878-888, 2013
3202013
ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas, ...
Annals of oncology 29 (8), 1658-1686, 2018
2982018
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
HS Haugnes, GJ Bosl, H Boer, JA Gietema, M Brydøy, J Oldenburg, ...
J Clin Oncol 30 (30), 3752-3763, 2012
2942012
Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses
J Oldenburg, GC Alfsen, HH Lien, N Aass, H Wæhre, SD Fosså
Journal of clinical oncology 21 (17), 3310-3317, 2003
2722003
Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors
J Oldenburg, SM Kraggerud, M Cvancarova, RA Lothe, SD Fossa
Journal of clinical oncology 25 (6), 708-714, 2007
2512007
Fear of recurrence in long‐term testicular cancer survivors
T Skaali, SD Fosså, R Bremnes, O Dahl, CF Haaland, ER Hauge, O Klepp, ...
Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2009
2232009
Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors
M Brydøy, J Oldenburg, O Klepp, RM Bremnes, EA Wist, ...
Journal of the National Cancer Institute 101 (24), 1682-1695, 2009
1892009
EAU guidelines on testicular cancer
MP Laguna, G Pizzocaro, O Klepp, F Algaba, L Kisbenedek, O Leiva
European urology 40 (2), 102-110, 2001
1852001
Impact of long-term serum platinum concentrations on neuro-and ototoxicity in cisplatin-treated survivors of testicular cancer
M Sprauten, TH Darrah, DR Peterson, ME Campbell, RE Hannigan, ...
Journal of Clinical Oncology 30 (3), 300, 2012
1812012
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
1662020
2-18fluoro-deoxy-D-glucose positron emission tomography (FDG-PET) for postchemotherapy seminoma residual lesions: a retrospective validation of the SEMPET trial
M Bachner, Y Loriot, M Gross-Goupil, PA Zucali, A Horwich, ...
Annals of oncology 23 (1), 59-64, 2012
1612012
One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group
T Tandstad, O Ståhl, U Håkansson, O Dahl, HS Haugnes, OH Klepp, ...
Annals of oncology 25 (11), 2167-2172, 2014
1582014
Late relapses of germ cell malignancies: incidence, management, and prognosis
J Oldenburg, JM Martin, SD Fosså
Journal of clinical oncology 24 (35), 5503-5511, 2006
1582006
Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study
C Fung, SD Fossa, MT Milano, J Oldenburg, LB Travis
Journal of clinical oncology 31 (30), 3807, 2013
1552013
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a report from the Swedish …
T Tandstad, O Ståhl, O Dahl, HS Haugnes, U Håkansson, Å Karlsdottir, ...
Annals of Oncology 27 (7), 1299-1304, 2016
1422016
Adverse prognostic factors for testicular cancer–specific survival: a population-based study of 27,948 patients
SD Fosså, M Cvancarova, L Chen, AL Allan, J Oldenburg, DR Peterson, ...
Journal of Clinical Oncology 29 (8), 963-970, 2011
1332011
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20